Table 1 The demographic information and clinical characteristics of all participants.
 | Controls (n = 35) | CIS (n = 41) | MS (n = 32) | F/T/χ2 /Z value | P value |
---|---|---|---|---|---|
Mean Age (years) | 35.0 ± 11.5 | 35.7 ± 10.7 | 34.8 ± 8.3 | 0.08 # | 0.92# |
Gender (F/M) | 23/12 | 26/15 | 24/8 | 1.17â•« | 0.56â•« |
Mean MMSE | 29.1 ± 1.3 | 27.6 ± 1.4 | 25.9 ± 1.8 | 36.44# | <0.001# |
Mean PASAT2 | 46.7 ± 9.2 | 39.4 ± 7.7 | 35.4 ± 9.8 | 14.14# | <0.001# |
Mean PASAT3 | 53.9 ± 6.2 | 47.5 ± 7.6 | 41.0 ± 8.7 | 24.38# | <0.001# |
Mean disease duration (months) | – | 2.6 ± 2.5 | 41.8 ± 28.7 | 8.73* | <0.001* |
Mean TWMLL (ml) | – | 4.5 ± 10.6 | 10.3 ± 10.4 | 2.33* | 0.023* |
Median EDSS (range) | – | 2.0 (0–6) | 3.5 (0–6.5) | 3.35§ | <0.001§ |